18/11/10

Nigerian traditional medicine institute at a standstill

Nigerian researchers may have to look for funding outside the country Copyright: IITA Image Library

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Nigerian traditional medicine institute at a standstill</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><span>A funding shortfall has caused research to cease at a Nigerian institute that develops drug candidates from traditional herbal remedies.</span></p>
<p><span>The National Institute for Pharmaceutical Research and Development (NIPRD), based in Abuja, has already developed a potential therapy for sickle-cell disease and has encouraging results for compounds to treat malaria and tuberculosis. </span></p>
<p><span>But a key grant from the US National Institute of Allergy and Infectious Diseases (NIAID) has run out and the Nigerian Ministry of Health has not covered the funding gap. As a result, research on drugs for all three diseases has largely ground to a halt. </span></p>
<p><span>"There are lots of things we don’t do because we have no money," said Karniyus Gamaniel, NIPRD’s director-general.</span></p>
<p><span>The funding gap will prevent further development of <a href="http://www.scidev.net/en/news/sufferers-urge-progress-on-sickle-cell-drug-nicosan.html">Nicosan (niprisan), the institute’s potential treatment for sickle-cell anaemia</a>.</span></p>
<p><span>Getting good phase III trial data is the "crucial next step" for developing the drug, said Marie Stuart, a professor of paediatrics and haematology at Thomas Jefferson University, United States.</span></p>
<p><span>But financial constraints have hindered NIPRD from doing further clinical trials, Gramaniel said. </span></p>
<p><span>Umar Bindir, director-general of Nigeria’s National Office for Technology Acquisition and Promotion, said ministries cannot fund any institute in excess of a yearly cap, fixed by the ministry of finance, so the chances of any further funding are slim.</span></p>
<p><span>"It doesn’t matter what you have as an institution and how important you are, the ceiling doesn’t change and it’s not good for R&D," said Bindir. "NIPRD has to intensify its own efforts by doing contract research for industry and submitting proposals to institutions such as the African Union and the European Union."</span></p>
<p><span><span><a target="_blank" href="http://www.nature.com/news/2010/101118/full/news.2010.602.html" rel="noopener noreferrer">Link to full article in <em>Nature</em></a></span></span></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/news/nigerian-traditional-medicine-institute-at-a-standstill/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/news/nigerian-traditional-medicine-institute-at-a-standstill/",null,true])
</script>
</div>

A funding shortfall has caused research to cease at a Nigerian institute that develops drug candidates from traditional herbal remedies.

The National Institute for Pharmaceutical Research and Development (NIPRD), based in Abuja, has already developed a potential therapy for sickle-cell disease and has encouraging results for compounds to treat malaria and tuberculosis.

But a key grant from the US National Institute of Allergy and Infectious Diseases (NIAID) has run out and the Nigerian Ministry of Health has not covered the funding gap. As a result, research on drugs for all three diseases has largely ground to a halt.

"There are lots of things we don’t do because we have no money," said Karniyus Gamaniel, NIPRD’s director-general.

The funding gap will prevent further development of Nicosan (niprisan), the institute’s potential treatment for sickle-cell anaemia.

Getting good phase III trial data is the "crucial next step" for developing the drug, said Marie Stuart, a professor of paediatrics and haematology at Thomas Jefferson University, United States.

But financial constraints have hindered NIPRD from doing further clinical trials, Gramaniel said.

Umar Bindir, director-general of Nigeria’s National Office for Technology Acquisition and Promotion, said ministries cannot fund any institute in excess of a yearly cap, fixed by the ministry of finance, so the chances of any further funding are slim.

"It doesn’t matter what you have as an institution and how important you are, the ceiling doesn’t change and it’s not good for R&D," said Bindir. "NIPRD has to intensify its own efforts by doing contract research for industry and submitting proposals to institutions such as the African Union and the European Union."

Link to full article in Nature